CME Presentations

Schizophrenia


Presentations


Speakers

  • Rajiv Tandon, MD

    Rajiv Tandon, MD

    Rajiv Tandon, MD

    Executive Vice-Chair and Professor, Department of Psychiatry

    Rajiv Tandon, MD, is a professor of psychiatry at the University of Florida College of Medicine in Gainesville. He is the immediate past-president of the Florida chapter of the National Alliance for Mental Illness, immediate past-president of the Florida Psychiatric Society, and was a member of the DSM-5 workgroup on schizophrenia and related psychotic disorders. Dr Tandon’s areas of clinical and research interest are the neuropharmacology of schizophrenia, differences between typical and atypical antipsychotic agents, dimensions of schizophrenic psychopathology, neuroendocrine and polysomnographic abnormalities in schizophrenia, and the evidence-based treatment of schizophrenia and other major mental disorders. He is a member of the World Psychiatry Association Pharmacopsychiatry Section.
  • Matcheri S. Keshavan, MD

    Matcheri S. Keshavan, MD

    Matcheri S. Keshavan, MD

    Stanley Cobb Professor and Vice-Chair for Public Psychiatry

    Matcheri S. Keshavan, MD, is Stanley Cobb Professor of Psychiatry at Harvard Medical School, vice-chair of public psychiatry at Beth Israel Deaconess Medical Center, and a senior psychiatric advisor for the Massachusetts Mental Health Center in Boston. Dr Keshavan’s research focuses on the neurobiology of psychosis, especially as it pertains to first episode psychotic disorders. He is editor-in-chief of Schizophrenia Research, and serves on the editorial board for Acta Neuropsychiatrica, Bipolar Disorders, and Asian Journal of Psychiatry. Dr Keshavan has more than 550 publications to date, including over 500 peer-reviewed papers and 4 books. He received his medical training in Mysore, India, and his psychiatric training in Bangalore, India, as well as Vienna, London, and Detroit, Michigan.

CME Information

Addressing Unmet Needs in Schizophrenia Management


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Employ appropriate strategies when transitioning between oral antipsychotic agents and respective long‐acting antipsychotic injections in patients with schizophrenia
  • Distinguish possible adverse metabolic abnormalities that may be associated with available antipsychotic agents
  • Address clinical consequences of nonadherence to antipsychotic therapy with strategies to address nonadherence
  • Assess the potential therapeutic benefits of newer and investigative agents in the treatment of schizophrenia

Acknowledgement

This activity is supported by an educational grant from Indivior Inc.

Tuition

Complimentary

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity
Thursday, March 21, 2019 from 12:00pm – 1:00pm EDT.

Enduring Material
The enduring material will be available from March 21, 2019 to March 21, 2020.

Target Audience

This activity is intended for psychiatrists, psychologists, family physicians, internal medicine physicians, advanced practice providers, nurses, pharmacists, and other HCPs involved in the care of patients with schizophrenia.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Matcheri S. Keshavan, MD
Stanley Cobb Professor and Vice-Chair for Public Psychiatry
Department of Psychiatry
Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center
Harvard Medical School

Reported Financial Relationship: None

Rajiv Tandon, MD
Executive Vice-Chair and Professor
Department of Psychiatry
University of Florida

Reported Financial Relationship: None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

David Howard
Medical Director
PlatformQ Health Education, LLC
Reported Financial Relationship: None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Discalimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support:
For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive at 877-394-1306 or at Support@PsychiatryLive.com